ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 166 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2019. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $791,000 | +93.9% | 170,404 | +108.9% | 0.00% | – |
| Q4 2021 | $408,000 | -60.5% | 81,571 | -4.9% | 0.00% | -100.0% |
| Q3 2021 | $1,034,000 | +6.9% | 85,818 | +87.8% | 0.00% | 0.0% |
| Q2 2021 | $967,000 | -39.9% | 45,703 | -20.3% | 0.00% | 0.0% |
| Q1 2021 | $1,608,000 | +44.5% | 57,343 | +34.0% | 0.00% | 0.0% |
| Q4 2020 | $1,113,000 | -31.4% | 42,794 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $1,622,000 | -45.9% | 43,642 | -25.3% | 0.00% | -50.0% |
| Q2 2020 | $2,996,000 | +97.5% | 58,384 | +21.3% | 0.00% | +100.0% |
| Q1 2020 | $1,517,000 | -26.9% | 48,113 | +38.2% | 0.00% | -50.0% |
| Q4 2019 | $2,076,000 | +106.0% | 34,822 | +26.7% | 0.00% | +100.0% |
| Q3 2019 | $1,008,000 | -12.0% | 27,486 | +11.6% | 0.00% | 0.0% |
| Q2 2019 | $1,146,000 | +25.5% | 24,639 | +8.4% | 0.00% | 0.0% |
| Q1 2019 | $913,000 | -2.8% | 22,736 | +11.3% | 0.00% | 0.0% |
| Q4 2018 | $939,000 | +5.0% | 20,420 | +1.4% | 0.00% | 0.0% |
| Q3 2018 | $894,000 | +8.2% | 20,141 | -4.4% | 0.00% | 0.0% |
| Q2 2018 | $826,000 | -75.0% | 21,079 | -53.9% | 0.00% | -66.7% |
| Q1 2018 | $3,305,000 | +11.7% | 45,693 | +1.7% | 0.00% | 0.0% |
| Q4 2017 | $2,959,000 | +19.7% | 44,943 | -8.9% | 0.00% | 0.0% |
| Q3 2017 | $2,473,000 | +6.5% | 49,335 | -1.6% | 0.00% | 0.0% |
| Q2 2017 | $2,321,000 | +34.8% | 50,148 | +2.8% | 0.00% | 0.0% |
| Q1 2017 | $1,722,000 | +697.2% | 48,762 | +183.2% | 0.00% | – |
| Q4 2016 | $216,000 | -26.3% | 17,218 | -18.7% | 0.00% | – |
| Q3 2016 | $293,000 | -30.9% | 21,167 | -50.7% | 0.00% | -100.0% |
| Q2 2016 | $424,000 | +142.3% | 42,903 | +315.0% | 0.00% | – |
| Q1 2016 | $175,000 | -58.8% | 10,337 | +98.7% | 0.00% | -100.0% |
| Q2 2015 | $425,000 | +3.7% | 5,203 | +17.5% | 0.00% | 0.0% |
| Q1 2015 | $410,000 | – | 4,428 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |